Abstract：Objective This study aimed to evaluate the feasibility and efficiency of surgical pulmonary embolectomy for acute pulmonary embolism. Methods The retrospective study was conducted. Clinical data of 51 patients with acute pulmonary embolism who received surgical pulmonary embolectomy in the First Affiliated Hospital of Anhui Medical University from October 2016 to July 2020 were analyzed. Of the patients, 22 were males, and 29 were females, with age of 61.7±13.1 (range, 22–78 years). During postoperative course, the clinical symptoms, occurrence of postoperative complications, pulmonary artery systolic pressure, and degree of tricuspid regurgitation were improved. Results All patients were successfully operated except for one patient who died of massive intraoperative respiratory tract hemorrhage. The median operative and cardiopulmonary bypass time were 221 (interquartile range, 139–303) min and 81 (interquartile range, 44–118) min, respectively. Clinical symptoms significantly relieved in 50 patients within 24 h after surgery. In addition, the changes in vital sings such as respiratory rate, heart rate, oxygen saturation, and arterial partial pressure of oxygen were significantly improved, and the difference was statistically significant (all P values <0.05). No death, recurrence of pulmonary embolism, or adverse bleeding events were recorded during follow-up from 7–41 months (average 19 months). Based on the echocardiography results of 34 patients at 1 and 6 months after operation, the pulmonary artery systolic pressure and degree of tricuspid regurgitation were significantly improved compared with that before operation (all P values <0.05). Conclusions Surgical pulmonary embolectomy is an effective treatment, which can be performed with satisfactory improvement of heart function for patients with acute pulmonary embolism, with a low rate of postoperative mortality and complication.
张朋, 张成鑫, 龚文辉, 葛圣林. 肺动脉切开取栓术在急性肺动脉栓塞治疗中的应用价值[J]. 中华解剖与临床杂志, 2022, 27(4): 251-255.
Zhang Peng, Zhang Chengxin, Gong Wenhui, Ge Shenglin. Application value of surgical pulmonary embolectomy in the treatment of acute pulmonary embolism. Chinese Journal of Anatomy and Clinics, 2022, 27(4): 251-255.
Ozsu S, Oztuna F, Bulbul Y, et al.The role of risk factors in delayed diagnosis of pulmonary embolism[J]. Am J Emerg Med, 2011,29(1):26-32. DOI: 10.1016/j.ajem.2009.07.005.
[2]
Lankeit M, Konstantinides S. Mortality risk assessment and the role of thrombolysis in pulmonary embolism[J]. Crit Care Clin, 2011, 27(4):953-967, vii-viii. DOI: 10.1016/j.ccc.2011.09.008.
[3]
Konstantinides SV, Meyer G, Becattini C, et al.2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)[J]. Eur Heart J, 2020,41(4):543-603. DOI: 10.1093/eurheartj/ehz405.
[4]
Kalra R, Bajaj NS, Arora P, et al.Surgical embolectomy for acute pulmonary embolism: systematic review and comprehensive Meta-analyses[J]. Ann Thorac Surg, 2017,103(3):982-990. DOI: 10.1016/j.athoracsur.2016.11.016.
[5]
Neely RC, Byrne JG, Gosev I, et al. Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients[J]. Ann Thorac Surg, 2015,100(4):1245-1251; discussion 1251-1252. DOI: 10.1016/j.athoracsur.2015.03.111.
[6]
Bloomfield P, Boon NA, de Bono DP. Indications for pulmonary embolectomy[J]. Lancet, 1988, 2(8606):329. DOI: 10.1016/s0140-6736(88)92374-4.
[7]
Kon ZN, Pasrija C, Bittle GJ, et al.The incidence and outcomes of surgical pulmonary embolectomy in North America[J]. Ann Thorac Surg, 2019, 107(5):1401-1408. DOI: 10.1016/j.athoracsur.2018.10.035.
[8]
Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association[J]. Circulation, 2011, 123(16):1788-1830. DOI: 10.1161/CIR.0b013e318214914f.
[9]
Mauritz GJ, Marcus JT, Westerhof N, et al.Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction[J]. Heart, 2011, 97(6):473-478. DOI: 10.1136/hrt.2010.193375.
[10]
Cohen AT, Agnelli G, Anderson FA, et al.Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality[J]. Thromb Haemost, 2007, 98(4):756-764.
[11]
Stein PD, Fowler SE, Goodman LR, et al.Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med, 2006, 354(22):2317-2327. DOI: 10.1056/NEJMoa052367.
[12]
Fukuda I, Daitoku K.Surgical Embolectomy for acute pulmonary thromboembolism[J]. Ann Vasc Dis, 2017,10(2):107-114. DOI: 10.3400/avd.ra.17-00038.
[13]
Lee T, Itagaki S, Chiang YP, et al. Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013[J]. J Thorac Cardiovasc Surg, 2018, 155(3):1084-1090.e12. DOI: 10.1016/j.jtcvs.2017.07.074.
[14]
Pasrija C, Kronfli A, Rouse M, et al. Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience[J]. J Thorac Cardiovasc Surg, 2018, 155(3):1095-1106.e2. DOI: 10.1016/j.jtcvs.2017.10.139.
[15]
Stein PD, Alnas M, Beemath A, et al.Outcome of pulmonary embolectomy[J]. Am J Cardiol, 2007, 99(3):421-423. DOI: 10.1016/j.amjcard.2006.08.050.
[16]
Keeling WB, Leshnower BG, Lasajanak Y, et al.Midterm benefits of surgical pulmonary embolectomy for acute pulmonary embolus on right ventricular function[J]. J Thorac Cardiovasc Surg, 2016, 152(3):872-878. DOI: 10.1016/j.jtcvs.2015.11.042.
[17]
Kearon C, Akl EA, Comerota AJ, et al.Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e419S-e496S. DOI: 10.1378/chest.11-2301.
[18]
Aymard T, Kadner A, Widmer A, et al.Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy—should surgical indications be revisited?[J]. Eur J Cardiothorac Surg, 2013, 43(1):90-94. DOI: 10.1093/ejcts/ezs123.
Gan HL, Zhang JQ, Zhou QW, et al.Surgical treatment of pulmonary artery sarcoma[J]. J Thorac Cardiovasc Surg, 2011, 142(6):1469-1472. DOI: 10.1016/j.jtcvs.2011.03.013.
[21]
Couturaud F, Sanchez O, Pernod G, et al.Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial[J]. JAMA, 2015, 314(1):31-40. DOI: 10.1001/jama.2015.7046.
[22]
Decousus H, Leizorovicz A, Parent F, et al.A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group[J]. N Engl J Med, 1998, 338(7):409-415. DOI: 10.1056/NEJM199802123380701.
[23]
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study[J]. Circulation, 2005, 112(3):416-422. DOI: 10.1161/CIRCULATIONAHA.104.512834.
[24]
Stein PD, Matta F, Lawrence FR, et al.Usefulness of inferior vena cava filters in unstable patients with acute pulmonary embolism and patients who underwent pulmonary embolectomy[J]. Am J Cardiol, 2018, 121(4):495-500. DOI: 10.1016/j.amjcard.2017.11.007.
2022, Vol. 27 
